E. Trivier

发表

Synthesis and structure-activity relationships for 1-(4-(piperidin-1-ylsulfonyl)phenyl)pyrrolidin-2-ones as novel non-carboxylate inhibitors of the aldo-keto reductase enzyme AKR1C3.

W. Denny, A. Turnbull, J. Flanagan, 2013, European journal of medicinal chemistry.

Chronic oxidative stress compromises telomere integrity and accelerates the onset of senescence in human endothelial cells

A. Akhmedov, D. Kurz, S. Decary, 2004, Journal of Cell Science.

Differential Regulation of Telomerase in Endothelial Cells by Fibroblast Growth Factor‐2 and Vascular Endothelial Growth Factor‐A: Association with Replicative Life Span

D. Kurz, J. Erusalimsky, Hsiu-Lin Huang, 2004, Annals of the New York Academy of Sciences.

Novel mutations in Rsk-2, the gene for Coffin-Lowry syndrome (CLS)

C. Schwartz, A. Hanauer, F. Abidi, 1999, European Journal of Human Genetics.

Discovery of potent inhibitors of the lysophospholipase autotaxin.

H. Ovaa, A. Turnbull, W. Moolenaar, 2016, Bioorganic & medicinal chemistry letters.

Optimization of TEAD P-Site Binding Fragment Hit into In Vivo Active Lead MSC-4106.

F. Freire, D. Musil, C. Dillon, 2022, Journal of medicinal chemistry.

Evidence against the involvement of nitric oxide in the modulation of telomerase activity or replicative capacity of human endothelial cells

M. Quintero, J. Erusalimsky, E. Trivier, 2007, Experimental Gerontology.

3-(3,4-Dihydroisoquinolin-2(1H)-ylsulfonyl)benzoic Acids: highly potent and selective inhibitors of the type 5 17-β-hydroxysteroid dehydrogenase AKR1C3.

W. Denny, A. Turnbull, D. G. Brooke, 2012, Journal of medicinal chemistry.

Selective AKR1C3 inhibitors do not recapitulate the anti-leukaemic activities of the pan-AKR1C inhibitor medroxyprogesterone acetate

U. Günther, F. Khanim, R. Hayden, 2014, British Journal of Cancer.

Fibroblast Growth Factor-2, But Not Vascular Endothelial Growth Factor, Upregulates Telomerase Activity in Human Endothelial Cells

Hsiu-Lin Huang, Jorge D. Erusalimsky, Ying Hong, 2003, Arteriosclerosis, thrombosis, and vascular biology.

Telomerase Activity in Human Endothelial Cells Fibroblast Growth Factor-2 , But Not Vascular Endothelial Growth Factor , Upregulates

T. Lüscher, S. Decary, Hsiu-Lin Huang, 2003 .

LIM kinases are required for invasive path generation by tumor and tumor-associated stromal cells

E. Sahai, K. Anderson, R. Scott, 2010, The Journal of cell biology.

Rapid immunoblot and kinase assay tests for a syndromal form of X linked mental retardation: Coffin-Lowry syndrome.

A. Hanauer, K. Merienne, W. Kress, 1998, Journal of medical genetics.

syndromal form ofX linked mental retardation: Coffin-Lowry syndrome

A. Hanauer, K. Merienne, A. Rossi, 2022 .

PAK4 regulates stemness and progression in endocrine resistant ER-positive metastatic breast cancer.

I. Dragoni, R. Clarke, A. Sims, 2019, Cancer letters.

PAK4 regulates stemness and progression in endocrine resistant ER-positive metastatic breast cancer

I. Dragoni, R. Clarke, A. Sims, 2019, bioRxiv.

Mutations in the kinase Rsk-2 associated with Coffin-Lowry syndrome

E. Zackai, J. Mandel, P. Sassone-Corsi, 1996, Nature.

Noncoding human Y RNAs are overexpressed in tumours and required for cell proliferation

T. Krude, E. Trivier, C. Christov, 2008, British Journal of Cancer.

Discovery, Development, and SAR of Aminothiazoles as LIMK Inhibitors with Cellular Anti-Invasive Properties.

M. Olson, D. Crighton, S. Boyd, 2015, Journal of medicinal chemistry.

Genetic analysis of new French X-linked juvenile retinoschisis kindreds using microsatellite markers closely linked to the RS locus: further narrowing of the RS candidate region

A. Hanauer, F. Peugnet, X. Zanlonghi, 1995, Human Genetics.

Expression analysis of RSK gene family members: the RSK2 gene, mutated in Coffin-Lowry syndrome, is prominently expressed in brain structures essential for cognitive function and learning.

A. Hanauer, M. Zeniou, E. Trivier, 2002, Human molecular genetics.

Coffin-Lowry syndrome: current status.

A. Hanauer, K. Merienne, S. Jacquot, 1999, American journal of medical genetics.

Morpholylureas are a new class of potent and selective inhibitors of the type 5 17-β-hydroxysteroid dehydrogenase (AKR1C3).

W. Denny, A. Turnbull, D. G. Brooke, 2014, Bioorganic & medicinal chemistry.

RYK, a Catalytically Inactive Receptor Tyrosine Kinase, Associates with EphB2 and EphB3 but Does Not Interact with AF-6*

T. Ganesan, E. Trivier, 2002, The Journal of Biological Chemistry.

3-(3,4-Dihydroisoquinolin-2(1H)-ylsulfonyl)benzoic acids; a New Class of Highly Potent and Selective Inhibitors of the Type 5 17-beta-hydroxysteroid Dehydrogenase AKR1C3

W. Denny, A. Turnbull, D. G. Brooke, 2012 .

Construction of a high-resolution linkage map for Xp22.1-p22.2 and refinement of the genetic localization of the Coffin-Lowry syndrome gene.

J. Weissenbach, V. Biancalana, E. Trivier, 1994, Genomics.

3-(3,4-Dihydroisoquinolin-2(1H)-ylsulfonyl)benzoic acids; a New Class of Highly Potent and Selective Inhibitors of the Type 5 17-beta-hydroxysteroid Dehydrogenase AKR1C3

W. Denny, A. Turnbull, D. G. Brooke, 2012 .